Skip to main content
PDEX logo

PDEX · Pro Dex Inc

Track PDEX — free
$67.02 -0.88 (-1.30%) At close · Aug 14
Market Cap
$213.98M
Shares
3.19M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$67.02 Open$68.60 Day$66.32–68.60 52W close$23.91–68.44 Avg vol 30d99K Short int171K · 5.3% float · 1.7d Short vol74% DataJan 2020–Aug 2026 Filing10-Q · Apr 30

Up next

FQ1-27 quarter ends
~Sep 30, 2026 Est
filed Apr 30, 2026

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 14.3 · calm Equity put/call 0.52
Technical
price trend
Strong Buy
50 / 200-day cross No cross
Price vs 200-day avg +36%
above
Price vs 50-day avg +9%
above
RSI (14) 61
neutral
MACD trend Positive
52-week position 97%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +17%
trailing
6-month return +66%
trailing
YTD return +74%
this year
Relative strength +52%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $62 › 200d $49 — 50d above 200d
Institutional flow Accumulating
+16% holders QoQ · +17 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.35% of float · ▲ +8.7% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
67 holders — near 3-yr high, broad support
Squeeze score 54
elevated · 0–100
Fundamentals
Strong
Revenue growth +24%
Y/Y
Gross margin 29%
expanding
EPS growth +345%
Y/Y
Free cash flow $-3.3M
Valuation P/E 18.7
below peers
Balance sheet $11.5M
net debt
Quant / Vol
risk profile
Very High
Volatility 62%
annualized · 1-yr
Max drawdown −50%
past year
ATR 5.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Buy
0 · 3 · 4
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+36% Bullish
Price vs 50-day avg
+9% Bullish
RSI (14)
61 Neutral
MACD trend
Positive Bullish
52-week position
97% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $62 › 200d $49 — 50d above 200d
Institutional flow Accumulating
+16% holders QoQ · +17 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.35% of float · ▲ +8.7% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
67 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $24 Now $67 · 97% Range high $68
vs 200-day avg +36% vs 50-day avg +9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Instruments & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PDEX
Pro Dex Inc
this stock
$213.98M +74.2% +23.7% 18.7 5.3%
ISRG
Intuitive Surgical Inc
$139.37B -30.3% +20.5% 45.3 1.9%
BDX
Becton Dickinson & Co
$49.96B +8.2% 3.7%
MDLN
Medline Inc.
$46.99B -14.9% +11.5% 2.6%
ALC
Alcon Inc
$35.89B -5.8% +10.5% 2.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
67
% held
23.0%
Net QoQ
-13.6K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
92
View
Short & Settlement
Short Interest Rising
Shares short
170.7K
Days to cover
1.7d
Change
+13.6K sh
View
Short Volume
Short vol %
74%
As of
Aug 14, 2026
Short Total
View
Fails to Deliver
FTD shares
1
Value
$63
As of
Jul 2, 2026
View
Off-Exchange
Off-exchange %
12.9%
Week of
Jul 6, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$66.6M
Net income (FY)
$9.0M
EPS diluted
$2.67
View
Buybacks
Authorized
shares 1.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Jun 17, 2026
This year
7
View
Proposed Sales
Value
$628.4K
Shares
10.0K
Filed
May 21, 2026
View

Performance

5D 20D 120D MTD YTD
PDEX +2.2% +16.8% +66.0% +14.4% +74.2%
SPY +0.4% +4.5% +13.8% +3.9% +13.9%
vs SPY +1.8% +12.4% +52.2% +10.5% +60.3%

Capital returns

Buyback program · as of Sep 30, 2022
Authorized
shares 1.00M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 788920 CUSIP 74265M205 13F (30d) 65 filings 65 filers Visit website Investor relations